171 related articles for article (PubMed ID: 7491675)
1. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
[TBL] [Abstract][Full Text] [Related]
2. [Significance of histocompatibility tests].
Nishigaki F; Nozaki M; Nakamura A; Taniguchi M; Kobayashi K; Hirano T
Rinsho Byori; 1990 Feb; 38(2):151-6. PubMed ID: 2139476
[TBL] [Abstract][Full Text] [Related]
3. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation.
Lavee J; Kormos RL; Duquesnoy RJ; Zerbe TR; Armitage JM; Vanek M; Hardesty RL; Griffith BP
J Heart Lung Transplant; 1991; 10(6):921-9; discussion 929-30. PubMed ID: 1756157
[TBL] [Abstract][Full Text] [Related]
4. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
Halloran PF; Schlaut J; Solez K; Srinivasa NS
Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
[TBL] [Abstract][Full Text] [Related]
5. Crossmatch procedures used in organ transplantation.
Gebel HM; Lebeck LK
Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966
[TBL] [Abstract][Full Text] [Related]
6. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study.
Hourmant M; Bignon JD; Cesbron A; Soulillou JP
Clin Transpl; 1990; ():301-9. PubMed ID: 2103154
[TBL] [Abstract][Full Text] [Related]
7. Conversion of IgG-mediated complement-dependent cytotoxicity by reducing reagents.
McIntyre JA; Boldt HD; Faulk WP; Halbrook H
J Heart Lung Transplant; 1991; 10(1 Pt 1):117-24. PubMed ID: 2007163
[TBL] [Abstract][Full Text] [Related]
8. Relevance of positive crossmatches in renal transplantation.
Horsburgh T; Mistry N; Weston S; Morgan J; Donnelly PK; Veitch PS; Bell PR
Transplant Proc; 1992 Dec; 24(6):2508-9. PubMed ID: 1465848
[No Abstract] [Full Text] [Related]
9. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features.
Freese DK; Snover DC; Sharp HL; Gross CR; Savick SK; Payne WD
Hepatology; 1991 May; 13(5):882-91. PubMed ID: 2029992
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
[No Abstract] [Full Text] [Related]
11. Hyperacute rejection in porcine liver transplantation. I. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum.
Merion RM; Colletti LM
Transplantation; 1990 May; 49(5):861-8. PubMed ID: 2139985
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches.
Braun WE
Clin Lab Med; 1991 Sep; 11(3):571-602. PubMed ID: 1934965
[TBL] [Abstract][Full Text] [Related]
13. Fewer acute rejection episodes and improved outcome in kidney-transplanted patients with selection criteria based on crossmatching.
Karuppan SS; Lindholm A; Möller E
Transplantation; 1992 Mar; 53(3):666-73. PubMed ID: 1549863
[TBL] [Abstract][Full Text] [Related]
14. Significance of the monocyte crossmatch in living-related transplantation.
Leichter HE; Ettenger RB; Robertson L; Fine RN
Child Nephrol Urol; 1990; 10(4):186-8. PubMed ID: 2088588
[TBL] [Abstract][Full Text] [Related]
15. The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation.
Thistlethwaite JR; Heffron TG; Stevens L; Buckingham M; Stuart JK; Stuart FP
Transplant Proc; 1990 Aug; 22(4):1897-8. PubMed ID: 2389478
[No Abstract] [Full Text] [Related]
16. Autoreactive lymphocytotoxic IgM antibodies in highly sensitized dialysis patients waiting for a kidney transplant: identification and clinical relevance.
Barocci S; Valente U; Gusmano R; Perfumo F; Cantarella S; Leprini A; Icardi A; Nocera A
Clin Nephrol; 1991 Jul; 36(1):12-20. PubMed ID: 1889147
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
[TBL] [Abstract][Full Text] [Related]
18. Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients.
Quiroga J; Colina I; Demetris AJ; Starzl TE; Van Thiel DH
Hepatology; 1991 Dec; 14(6):1054-62. PubMed ID: 1959853
[TBL] [Abstract][Full Text] [Related]
19. Crossmatch with donor skin: its correlation with early rejection of kidney transplants.
Lasmar E; Távora E; Salomão A; Bambirra E; Penafiel P; Vilaça S
Transplant Proc; 1992 Dec; 24(6):3070-1. PubMed ID: 1466059
[No Abstract] [Full Text] [Related]
20. AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survival.
Kerman RH; Kimball PM; Van Buren CT; Lewis RM; DeVera V; Baghdahsarian V; Heydari A; Kahan BD
Transplantation; 1991 Feb; 51(2):316-20. PubMed ID: 1994522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
